Effect of Continuous Positive Airway Pressure Treatment on Inflammation in Patients With Obstructive Sleep Apnea
A Longitudinal Study of Short-Term Effects of CPAP Treatment on Airway and Systemic Inflammation in Patients With Obstructive Sleep Apnea
1 other identifier
interventional
43
1 country
1
Brief Summary
The purpose of this study is to evaluate the effects of CPAP treatment on airway and systemic inflammation in obstructive sleep apnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2008
CompletedFirst Posted
Study publicly available on registry
October 28, 2008
CompletedStudy Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedMarch 27, 2013
March 1, 2013
2.2 years
October 27, 2008
March 25, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Inflammatory biomarkers in induced sputum and blood. Cell counts in induced sputum.
3 months
Secondary Outcomes (6)
NO in exhaled breath
3 months
Airway resistance
3 months
PSG measurement(AHI,etc.)
3 months
Quality of Life
3 months
Psychological status
3 months
- +1 more secondary outcomes
Study Arms (1)
CPAP
EXPERIMENTALInterventions
maintains upper airway patency and minimizes the obstructive events
Eligibility Criteria
You may qualify if:
- Subjects on admission for sleep study under the Respiratory Care and Sleep Control Medicine, Kyoto University Hospital.
- Subjects diagnosed with OSA (apnea hypopnea index \>=20/hour) by overnight polysomnography.
You may not qualify if:
- Known history of respiratory diseases that will affect airway inflammatory markers like asthma, chronic obstructive pulmonary disease and bronchiectasis.
- Treatments with corticosteroids or other immunosuppressive drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kyoto University Graduate School of Medicine
Kyoto, Kyoto, 6068507, Japan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kazuo Chin, MD,PhD
Kyoto University, Graduate School of Medicine
- PRINCIPAL INVESTIGATOR
Toru Oga, MD,PhD
Kyoto University, Graduate School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Respiratory Care and Sleep Control Medicine, Kyoto University Graduate School of Medicine
Study Record Dates
First Submitted
October 27, 2008
First Posted
October 28, 2008
Study Start
January 1, 2009
Primary Completion
March 1, 2011
Study Completion
March 1, 2011
Last Updated
March 27, 2013
Record last verified: 2013-03